UvA-DARE is a service provided by the library of the University of Amsterdam (https://dare.uva.nl)
UvA-DARE (Digital Academic Repository)
Early risk stratification in patients with chest pain
Bholasingh, R.
Publication date2004
Link to publication
Citation for published version (APA):Bholasingh, R. (2004). Early risk stratification in patients with chest pain.
General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s)and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an opencontent license (like Creative Commons).
Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, pleaselet the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the materialinaccessible and/or remove it from the website. Please Ask the Library: https://uba.uva.nl/en/contact, or a letterto: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. Youwill be contacted as soon as possible.
Download date:08 Jun 2021
https://dare.uva.nl/personal/pure/en/publications/early-risk-stratification-in-patients-with-chest-pain(14b97916-a9e5-478c-9137-78b5ca9c6775).html
Chapterr 4
Robbertt J. de Winter Radhaa Bholasingh
Annee B. Nieuwenhuijs Rudolph.. W. Koster
Ronn J. G. Peters Gerard.. T. Sanders
Rulingg out acute myocardial infarctionn early with two seriall creatine-kinase MBmass determinations s
EurEur Heart J 1999;20:967-972
RulingRuling out myocardial infarction
ABSTRACT T
Objective e
Wee studied the diagnostic value for acute myocardial infarction of serial creatine kinase-
MBnasss measurements on admission and at 7 hours after the onset of symptoms.
Methodss and results
Patientss presenting to our chest pain unit with symptoms of < 5 hours duration were eligible.
Patientss were kept under observation at least untill 12 hours after onset of symptoms.
Bloodsampless were drawn on admission, 7 and 10 hours after onset of symptoms. Creatine
kinase-MBnuBss >7.0 ug/1 (upper reference limit for acute myocardial infarction), or an increase
>> 2.0 ug/1 (reference change value) between admission and at 7 hours was considered
abnormal.. Of a total of 470 patients, 248 patients had acute myocardial infarction: 100/248
patientss had a single creatine kinase-MB,̂ >7.0 ug/1 on admission (sensitivity 40%, 95%
C.I.:34-36),, 234/248 patients at 7 hours (sensitivity 94%, 95% CI.:91-97), and 240/248 at 10
hourss (sensitivity 97%, 95% C.L:94-99). At 7 hours, 246/248 patients either had a single
creatinee kinase-MBmass >7.0ug/l or a significant increase between admission and 7 hours
(sensitivityy 99%* 95% C.I.: 98-100). Of 222 patients without acute myocardial infarction, 214
hadd a normal serial creatine kinase-MBn,̂ (specificity 96%, 95% CI. :93-98).
Conclusion n
Inpatientss with symptoms of < 5 hours duration, acute myocardial infarction can be ruled-out
inn 99% using serial creatine kinase-MB,,̂ taken on admission and at 7 hours.
50 0
ChapterChapter 4
INTRODUCTION N
Earlyy diagnosis of acute myocardial infarction may improve treatment and reduce
complications.. Conversely, identification of low-risk patiënte without myocardial infarction
mayy allow for early triage and the rational use of intensive care facilities. Goldman et al.(30),
evaluatingg the need for intensive care in patients with acute chest pain, snowed that the risk of
majorr complications could be estimated on the basis of clinical presentation (symptoms,
physicall examination, electrocardiogram) and an additional 12-hours observation period.
However,, others have demonstrated that 4-8% of patients with myocardial infarction may be
missed(107).. Patients in whom the diagnosis of myocardial infarction is missed and who are
inadvertentlyy discharged from the emergency department, have increased short-term mortality
comparedd with admitted patients(4). New rapid assays for creatine lanase-MBmas, with
excellentt precision in the normal concentration range are now available for early and more
accuratee diagnosis of myocardial infarction(29;83;108;109). We(29;86) and others(110;Ul),
havee shown that, with me high precision of creatine kinase-MBmass assays, a so-called
referencee Change value (or critical difference) can be calculated A significant increase in
seriall creatine kinase-MBnBB» which can occur within the reference limit, is defined as a
differencee larger than the reference change-Value, and such an increase signifies myocardial
damage(90).. Using mis definition in the interpretation of serial creatine kinase-MB
measurementss could increase sensitivity for the early detection of myocardial damage. We
havee shown previously that sensitivity of a single value does not reach 100% untill 12-16
hourss after the onset of symptoms(29;44). In the present study, we assessed the diagnostic
valuee of two creatine kinase-MBmagg samples taken on admission and at 7 hours, and the
additionall value of a third sample at 10 hours. The study question was whether myocardial
infarctionn could already be recognized or ruled out with high sensitivity on the basis of an
abnormall serial creatine kmase-MBaass measured on admission and at 7 hours
METHODS S
Fromm the 1996 database of the "cardiac emergency room" or chest pain unit of the Academic
Medicall Center (The Netherlands), all patients were reviewed with admission diagnosis of
typicall chest pain. Patients were included when the onset of symptoms was
RulingRuling out myocardial infarction
fromfrom admission, 7 and 10 hours after die onset of symptoms according to our routine protocol.
Hospitall records were reviewed to assess patients' characteristics, in-hospital clinical course
andd discharge diagnosis.
Acutee myocardial infarction was prospectively defined according to World Health
Organizationn criteria(87), using a typical history, definite electrocardiogram changes and an
increasee in creatine kinase-MBn̂ levels. A final diagnosis of acute myocardial infarction was
retrospectivelyy established by one of the investigators (R.B.) combining discharge diagnosis
fromfrom hospital records, electrocardiogram findings and creatine kinase-MBnass results from all
timee points. The upper reference limit for myocardial infarction was 7.0 ug/1.
Creatinee kinase-MBnass was measured with the IMMUNO-1 analyzer (Bayer, Leverkusen,
Germany);; the coefficient of variation was 2.5% at 5.0 ug/1, me turn-around time of the assay
wass 1 hour.
InIn all patients, creatine kinase-MBnass was measured on admission and at 7 and 10 hours.
Whenn creatine kinase-MB,,̂ at any of these three time point was >7.0 ug/1 or when a
significantt increase between two samples (>2.0 ug/I) was present, patients were admitted to
thee coronary care unit and additional creatine kinase-MBnass measurements were made at 12
hourss and at 4-hour intervals thereafter untill a peak value was reached. Patients who had
recurrentt symptoms with concommittant electrocardiographic changes while under
observationn in the cardiac emergency room were diagnosed as severely unstable angina and
admittedd to die coronary care unit irrespective of creatine kinase-MBnass results, as were aU
otherr patients in whom the attending cardiologist decided that coronary care unit monitoring
wass necessary. Patients without evidence of myocardial damage and without recurrent
symptomss while under observation until 12 hours after the onset of symptoms, were usually
discharged.. Symptom limited exercise tests, echocardiograms or other diagnostic procedures
beforee discharge from the cardiac emergency room were ordered at the discretion of the
attendingg cardiologist.
Interpretationn of serial creatine kinase-MBmass samples was as follows: creatine kinase-MÊ
>7.00 ug/1 were considered indicative of myocardial infarction. A difference between
admissionn and 7 hours >2.0 ug/1 (significant increase), was considered abnormal (figure 1). A
creatinee kinase-MBnass 7.0 ug/1 on admission, 7 hours, 10 hours, or any time point
52 2
ChapterChapter 4
thereafter)) was calculated for a single creatine kinase-MBmas, at time points admission, 7
hours,, and for the serial creatine kinase-MBnass combining these two time points. Confidence
intervalss for sensitivity and specificity were calculated with the formula for a binomial
distributionn x s.e., where s.e.=V[p(l-p)/n]. The investigation conformed with the
principless outlined in the Declaration of Helsinki
RESULTS S
Théé database included 1179 patients coded for "presenting with chest pain". A total of 680
patientss were excluded owing to admission later than 5 hours after the onset of symptoms
(2355 patients), or because of atypical chest fain, arrhythmias, congestive heart failure or non-
cardiacc disease where creatine kinase-MBnass samples were not drawn according to protocol
(4388 patients). In 7 patients, creatine lunase-MB,̂ samples were missing due to cardiogenic
shockk or large myocardial infarction, where urgent treatment interfered with marker
measurements.. The remaining 499 patients were presenting within 5 hours after the onset of
symptomss and had complete series of creatine kinase-MBmass samples taken on admission, 7
andd 10 hours. Because of incomplete, equivocal or missing hospital records, another 29
patientss were excluded and therefore 470 patients comprised the study group. Table 1 shows
thee patients* characteristics which were representative of those of chest pain patients admitted
too the cardiac emergency room. Myocardial infarction was diagnosed in 248 patients (table 2):
1000 patients with a creatine kmase-MBâ >7.0 ug/1 on admission (sensitivity: 40%, 95%C.I.:
34-46),, 234 patients with a creatine kmase-MB,̂ >7.0 ug/1 at 7 hours (sensitivity: 94%,
95%C.L:: 91-97), and 240 patients with a creatine kinase-MB̂ >7.0 ug/1 at 10 hours
(sensitivity:: 97%, 95% C.L: 94-99). A total of 254 patients had an abnormal serial creatine
kmase-MBnro;; 237 patients with a creatine kinase-MBmass >7.0 ug/1 either on admission
and/orr 7 hours, and 17 patients with a significant increase between admission and 7 hours but
noo creatine kinase-MB̂ >7.0 ug/1 at either time point. Qf these 17 patients, 9 were
diagnosedd as myocardial infarction with a creatine kmase-MBmass release curve that continued
too increase above 7.0ug/l at 10 h (table 3, patients 1-9; figure 1). The other 8 patients had a
significantt increase between admission and 7 hours but a creatine kinase-MBnass at 10 hours
beloww 7.0 ug/1 (table 3, patients 10-17; figure 1). Of 216 patients with a normal serial creatine
kinase-MBmasgg on admission and at 7 hours, 214 patients had a creatine kinase-MB̂ below
7.00 ug/1 at 10 hours. Two patients had a creatine kinase-MBraB» at 10 hours above 7.0ug/L, one
53 3
RulingRuling out myocardial infarction
off these patients (who was diagnosed as myocardial infarction) was resuscitated outside the
hospitall and admitted to the emergency room in cardiogenic shock, the other patient was
admittedd with severe unstable angina with repetitive episodes of recurrent angina after
admissionn and later diagnosed as myocardial infarction (table 3, patients a and b). There were
1377 patients with ST-elevation on the admission electrocardiogram, 131 with myocardial
infarctionn and 6 without myocardial infarction. ST-depression or T-wave changes was present
inn 167 patients, 67 with myocardial infarction and 100 without myocardial infarction. Of the
remainingg 166 patients with either a non-diagnostic or a normal electrocardiogram, 50 had
myocardiall infarction and 116 did not have myocardial infarction. The sensitivity and
specificityy of an abnormal serial creatine kinase-MBmagj according to admission
electrocardiogramm is depicted in figure 2, demonstrating no significant differences between
groups. .
Inn summary, of 248 patients diagnosed as myocardial infarction, 246 were identified with
seriall creatine lunase-MB,̂ on admission and at 7 hours (sensitivity 99%, 95% CI.: 98-100).
Off 222 patients not diagnosed as myocardial infarction, 214 had normal serial creatine kinase-
MBmasss (specificity 96%, 95% CI.: 93-99).
DISCUSSION N
Inn the present study we analyzed the value of serial samples taken on admission (before 5
hours)) and at 7 hours after the onset of symptoms, and compared this with a single
measurementt taken on admission, at 7 hours and at 10 hours. The combined information from
thee creatine kinase-MBmasg measurement on admission and at 7 hours had a sensitivity of 99%,
higherr than for a single measurement at each of these three time points. Of 216 patients with a
normall serial creatine Jonase-MB,̂ in only two patients did creatine kinase-MBmass at 10
hourss increase (unexpectedly) above 7.0 ug/1. One patient was resuscitated outside the
hospitall but the onset of symptoms was thought to have occurred prior to the time of cardiac
arrest;; the other was admitted with severe unstable angina and may have had another episode
off severe ischemia after admission mat caused a late increase of creatine kinase-ME^a,». Both
thesee patients had a clinical presentation that made admission to the coronary care unit
necessary,, irrespective of the creatine kinase-MBroass results. The specificity of the presented
algorithmm was only 96%: eight patients had an increase between admission and 7 hours >2.0
ug/11 but no diagnosis of myocardial infarction, thus lowering specificity (although it could be
54 4
ChapterChapter 4
arguedd that these patients had indeed signs of myocardial damage). The sensitivity of this
algorilhmm was similarly high in patients with ST-elevation, ST-depression or non-diagnostic
orr normal electrocardiograms on admission. Specificity was 83% (5 of 6) in the small group
off patients with ST-elevation but without infarction.
Thee upper reference limit of the creatine kinase-MÊ assay was established using the 95m
percentilee of the distribution of healthy donors (7.0 ug/1 for the IMMUNO-1 assay in our
institution).. However, the distribution of healthy donors is heavily skewed to the right, and for
mostt healthy individuals, the normal creatine kinase-MBasss is around 1.5-2.5 ug/L For these
individualss a creatine kmase-MBn̂ of e.g. 5.0 ug/1 can be abnormal, although it is still within
thee reference limits. Using serial sampling with carefully timed bloodsamples, the difference
betweenn samples detects abnormal creatine kinase-MB̂ changes within the reference limits.
Neww assays for creatine kmase-MBmasa have very good precision in the normal concentration
range,, the assay used in mis study had a coefficient of variation of 2.5% in the range of 5.0
ug/LL Moreover, biological variation of creatine kinase-MBmass is small(29;86;ni), therefore
thee reference change-value or me maximum change in creatine kinase-MBmass due to
analyticall and biological variation is only 2.0 ug/1 for values within me reference limits. The
analyticall variation for creatine kmase-MB̂ 2.5% at 5.0 ug/I with the IMMUNO-1 assay in
ourr laboratory, which is somewhat better man the 6.8% recently reported by Ross et al. tor the
OBA
RulingRuling out myocardial infarction
withinn 24 hours(29;86), whereas others have demonstrated that a significant increase in
creatinee kinase-MBmass has prognostic implication̂ 110;111).
Theree are some limitations to the study. Including only those patients in the study presenting
withinn 5 hours after onset of symptoms and with a complete series of creatine kinase-MBjnass
sampless may have preferentially selected patiënte with myocardial infarction and patients with
aa clear time of onset of symptoms. However, in many patients which were coded 'presenting
withh chest pain' in the database, creatine kinase-MBma» measurements were not performed
owingg to a low suspicion of ischemic myocardial injury. Therefore, patients in whom creatine
kinase-MBmasss measurements were considered relevant were included in thee study. Secondly,
ourr study was a retrospective study, and whether a sampling protocol with two serial creatine
kinase-MBaasss measurements on admission and at 7 hours will allow safe discharge at that
timee point of patients with normal results (both creatine kinase-MBmass results ^7.0 ug/1,
differencee
ChapterChapter 4
RCV V
Admission n «« *
100 15 20
Timee after onset of symptoms 2.0ug/l,
whichh may signify minor myocardial damage (patient nr. 13, table 3).
57 7
RulingRuling out myocardial infarction
#f f >J»--
o o i i «ft t > >
—
> > m m
100 0
80 0
60 0
40 0
20 0 & &
0 0 ST-elevatt ion ST-deprcwssion / Non-diagnostic /
T-wavoo changes normal ECG
n=137 7 ami=131 1
n=167 7 ami=67 7
n=166 6 amm i=50
Figuree 2.
Sensitivityy (shaded columns) and specificity (solid columns) of the algorithm for an abnormal serial creatine kinase-
MBmaa,, (>7.0ug/l on admission or at 7 h or a rise between admission and 7 h >2.0ug/l) for the diagnosis of acute
myocardiall infarction (ami). Patients are grouped according to the admission electrocardiogram: the presence of ST-
elevation,, ST-depression or T-wave changes, or non-diagnostic or normal. There were no significant differences in
sensitivityy and specificity between groups.
58 8
ChapterChapter 4
Tablee 1, Characteristics of 470 study patients with chest pain suggestive of myocardial
ischemiaa presenting within 5 hours after the onset of symptoms
Characteristic c
Males s
Females s
Agee (years; median» range)
Historyy of:
Acutee myocardial infarction
CABG G
PTCA A
Angina a
Riskk factors;
Smoking g
Hypertension n
Diabetess Mellitus
Hyperiipidemia a
Positivee family history
Medication: :
Aspirin n
B-blockers s
Nitrates s
Ca-antagonists s
Noo medication
Admissionn ECG: ST-elevation n
ST-depressionn / T-wave changes
Non-diagnosticc /normal
Number r
328 8 142 2
64(31-93) )
157 7 80 0 90 0
251 1
153 3 156 6 73 3
100 0 127 7
188 8
160 0 191 1
167 7 175 5
153 3
125 5 192 2
(%) ) 70 0 30 0
33 3 17 7 19 9 53 3
33 3
33 3 16 6 21 1 27 7
40 0 34 4 41 1
36 6
37 7
32 2
27 7 41 1
CABG== coronary artery bypass grafting; ECG, electrocardiogram; PTCA=percutaneous transluminal coronary
59 9
RulingRuling out myocardial infarction
Tablee 2. Number of patients with and without acute myocardial infarction diagnosed with a
creatinee kinase-MBmass >7.0ug/l at admission or 7 hours after the onset of symptoms and
additionall patients identified with a significant increase between these time points
Acutee No acute Myocardiall myocardial infarctionn infarction
(n=248)) (n=222)
Creatinee kinase-MB̂ >7.0 ug/1 Ta and/or T7
Significantt increase Ta-T7 and creatinee Jonase-MB̂ > 7.0 ug/1 at T10
Noo significant increase Ta-T7 and creatinee tanase-MB̂ > 7.0 ug/1 at T10
Significantt increase Ta-T7 and creatinee kinase-MBmass ̂ 7.0 ug/1 at T10
Noo significant increase Ta-T7 and creatinee kJnase-MBn̂
ChapterChapter 4
Tablee 3. Creatine kinase M B ^ results in individual patients
Patientt no.
1 1
2 2
3 3
4 4
5 5
6 6
7 7
8 8
9 9
10 0
11 1
12 2
13 3
14 4
15 5
16 6
17 7
a a
b b
Ta a
2.7 7
1.0 0
1.6 6
1.6 6
1.2 2
3.6 6
2.6 6
2.6 6
1.8 8
2.5 5
1.8 8
2.3 3
3.2 2
1.1 1
2.8 8
2.3 3
22 22
2.9 9
3.2 2
T7 7
6.9 9
3.1 1
4.6 6
5.6 6
6.3 3
6.6 6
4.8 8
7.0 0
6.5 5
5.0 0
5.3 3
5.3 3
6.0 0
4.6 6
5.4 4
6.4 4
6.7 7
1.8 8
2.5 5
A C K - M B ^ C H - T a) )
4.2 2
2.1 1
3.0 0
4.0 0
5.1 1
3.0 0
2.2 2
4.4 4
4.7 7
2.5 5
3.5 5
2.8 8
2.8 8
3.5 5
2.6 6
4.1 1
4.5 5
-1.1 1
-0.7 7
T10 0
499 9
7.9 9
13.1 1
7.2 2
7.2 2
8.3 3
12.0 0
7.3 3
10.1 1
5.7 7
5.6 6
3.8 8
6.7 7
6.0 0
4.3 3
6.9 9
6.8 8
14.2 2
9.6 6
CK-MB,»,, results in 9 patients (patients 1-9) with a significant increase (>2.0ug/l) between admission and 7 hours
afterr the onset of symptoms and with a CK-MB ^ above 7.0 u/l at 10 hours. There were 8 patients (patients 10-17)
withh a significant increase between admission and at 7 hou» after the onset of symptoms but with a CK-MB ^ at T10
beloww 7.0 ug/1. An additional 2 patients did not have a significant increase between admission and at 7 hours after the
onsett of symptoms but with a CK-MB™,, at T10 above 7.0 ug/1 (patients a and b).
CK-MBBB ^^ creatine kinase MBaa»; Ta*= time of admission; T7= seven hours after the onset of symptoms; T10= ten
hourss after the onset of symptoms.
61 1